2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Monarq Asset Management Announces Strategic Investment From FalconX
NEW YORK, June 3, 2025 /PRNewswire/ -- Monarq Asset Management ("Monarq"), a leading multi-strategy investment firm, formerly known as MNNC Group, today announced a strategic investment from FalconX, a leading institutional digital asset prime...
OHI Group S.A. Announces Consent Solicitation Relating to its U.S.$400,000,000 13.000% Senior Secured Amortizing Notes due 2029 Regulation S Notes: CUSIP L7S61M AB5, ISIN USL7S61MAB59 Rule 144A Notes: CUSIP 67712M AB5, ISIN US67712MAB54 (the "Notes")
Executive Summary — As previously announced, OHI Group S.A. (the "Issuer") is preparing a proposed initial public offering of its shares in the United States, to be registered with the U.S. Securities and Exchange Commission (the "SEC") and likely...
WASHINGTON FREEDOM ANNOUNCES MULTI-YEAR PARTNERSHIP WITH CLOVER
Clover joins Washington Freedom as Official Partner and Kit Sponsor to elevate fan experience and expand cricket's reach in the U.S. WASHINGTON, June 2, 2025 /PRNewswire/ -- Washington Freedom, the first professional cricket franchise representing...
DTX Group Debuts as Global Force, Powered by Strategic Vision and Independence Under Hussein Lookmanjee's Leadership
Backed by years of preparation and a clear global strategy, DTX Group launches to capitalize on emerging market opportunities and reshape the international aviation maintenance landscape. DUBAI, UAE, June 2, 2025 /PRNewswire/ -- DTX Group proudly...
Junee Limited Announces Completion of Corporate Name Change to SuperX AI Technology Limited and Commencement of Trading Under New Ticker Symbol "SUPX"
SINGAPORE, June 2, 2025 /PRNewswire/ -- NASDAQ-listed company Junee Limited (NASDAQ: JUNE) today announced that it has completed its previously announced corporate name change and re-branding to SuperX AI Technology Limited ("SuperX" or the...
OnCusp Therapeutics Announces Encouraging Initial Phase 1a Results from Ongoing First-in-Human Study Evaluating its CDH6-Directed Antibody-Drug Conjugate, CUSP06, in Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors at the 2025
CUSP06 is a CDH6-directed ADC with a differentiated profile and potentially best-in-class activity CUSP06 demonstrated a manageable safety profile, consistent with other TOP1-inhibitor ADCs Promising signs of efficacy were observed in patients with...
TuniTuni Opens New Storytelling Kids' Gym in Shek Mun, Hong Kong
HONG KONG, June 2, 2025 /PRNewswire/ -- TuniTuni, the beloved Korean kids' gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan...
CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting
SHANGHAI, June 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China...
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer
SAN FRANCISCO, and SUZHOU, China, June 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...